Yong-Qiu Mao Selected Research

Yong-Qiu Mao Research Topics

Disease

25	Neoplasms (Cancer) 01/2012 - 09/2003
5	Carcinoma (Carcinomatosis) 01/2012 - 10/2007
4	Neoplasm Metastasis (Metastasis) 11/2010 - 11/2004
4	Lung Neoplasms (Lung Cancer) 01/2009 - 10/2004
3	Hepatocellular Carcinoma (Hepatoma) 01/2012 - 03/2006
3	Breast Neoplasms (Breast Cancer) 11/2010 - 09/2008
2	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2015 - 08/2010
2	Adenocarcinoma of Lung 07/2010 - 10/2004
2	Uveitis 01/2010 - 11/2009
2	Leukemia 08/2006 - 12/2005
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2011
1	Colorectal Neoplasms (Colorectal Cancer) 01/2011
1	Prostatic Neoplasms (Prostate Cancer) 01/2011
1	Necrosis 11/2009
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 06/2008
1	Experimental Melanoma 10/2007
1	Body Weight (Weight, Body) 10/2007
1	Melanoma (Melanoma, Malignant) 03/2006
1	Proteinuria 03/2006
1	Glomerulonephritis 03/2006
1	Lewis Lung Carcinoma 10/2004
1	Vesicular Stomatitis 10/2004

Drug/Important Bio-Agent (IBA)

6	VaccinesIBA 06/2008 - 09/2003
4	AlginatesIBA 01/2011 - 09/2003
4	Liposomes (Liposome)IBA 01/2011 - 09/2008
4	AntigensIBA 08/2010 - 07/2004
4	Cisplatin (Platino)FDA LinkGeneric 08/2006 - 01/2004
4	Immunoglobulins (Immunoglobulin)IBA 03/2006 - 09/2003
3	SurvivinIBA 01/2011 - 09/2008
3	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 01/2011 - 09/2008
3	AutoantibodiesIBA 03/2006 - 07/2004
3	Proteins (Proteins, Gene)FDA Link 03/2006 - 09/2003
3	Gemcitabine FDA Link 06/2005 - 10/2004
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 04/2005 - 09/2003
2	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 04/2015 - 08/2010
2	Interleukin-4 (Interleukin 4)IBA 04/2015 - 08/2010
2	Antineoplastic Agents (Antineoplastics)IBA 01/2012 - 12/2011
2	Saline SolutionIBA 01/2011 - 04/2005
2	Pharmaceutical PreparationsIBA 07/2010 - 08/2006
2	Alanine (L-Alanine)FDA Link 01/2010 - 09/2008
2	Peptides (Polypeptides)IBA 01/2010 - 11/2009
2	Threonine (L-Threonine)FDA Link 01/2010 - 09/2008
2	Coloring Agents (Dyes)IBA 11/2009 - 11/2007
2	Combined VaccinesIBA 04/2005 - 01/2004
2	EndoglinIBA 11/2004 - 07/2004
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2015
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2015
1	Hematoxylin (Haematoxylon)IBA 04/2015
1	InterleukinsIBA 04/2015
1	3- amino- 6- (3,4- dichlorophenyl)thieno(2,3- b)pyridine- 2- carboxamideIBA 01/2012
1	benzocycloheptapyridineIBA 01/2012
1	thienopyridineIBA 01/2012
1	picolinamideIBA 01/2011
1	N- methyl- 4- (4- (3- (trifluoromethyl)benzamido)phenoxy)picolinamideIBA 01/2011
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2011
1	Phosphotransferases (Kinase)IBA 01/2011
1	Therapeutic UsesIBA 01/2011
1	Tyrosine (L-Tyrosine)FDA Link 01/2011
1	chloroquine diphosphate FDA LinkGeneric 11/2010
1	DNA (Deoxyribonucleic Acid)IBA 08/2010
1	MitogensIBA 08/2010
1	CytokinesIBA 08/2010
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2010
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 07/2010
1	IntegrinsIBA 07/2010
1	heparanaseIBA 07/2010
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 07/2010
1	Nadroparin (Nadroparin Calcium)IBA 07/2010
1	PolymersIBA 01/2010
1	Antimicrobial PeptidesIBA 11/2009
1	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 11/2009
1	IsoflavonesIBA 01/2009
1	barbigeroneIBA 01/2009
1	LipopolysaccharidesIBA 06/2008
1	Interleukin-6 (Interleukin 6)IBA 06/2008
1	Lymphotoxin-alpha (Lymphotoxin)IBA 06/2008
1	Cytostatic AgentsIBA 11/2007
1	FlavonoidsIBA 11/2007
1	QuercetinIBA 11/2007
1	Trypan Blue FDA Link 11/2007
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 11/2007
1	Mitoxantrone (Novantrone)FDA LinkGeneric 08/2006
1	homocamptothecinIBA 08/2006
1	hydroxycamptothecinumIBA 08/2006
1	HomoharringtonineIBA 08/2006
1	Annexin A5IBA 08/2006
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2006
1	anti-dsDNA autoantibodyIBA 03/2006
1	theasinensin AIBA 12/2005
1	EndostatinsIBA 06/2005
1	EnzymesIBA 04/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2005
1	Biological ProductsIBA 01/2005

Therapy/Procedure

15	Therapeutics 01/2011 - 09/2003
5	Immunotherapy 03/2006 - 09/2003
4	Drug Therapy (Chemotherapy) 06/2005 - 11/2004
3	Biological Therapy 08/2010 - 11/2004
2	Subcutaneous Injections 04/2015 - 08/2010
1	Intravenous Injections 01/2010
1	Transplantation 06/2008